1. Home
  2. TOMZ vs LPCN Comparison

TOMZ vs LPCN Comparison

Compare TOMZ & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOMI Environmental Solutions Inc.

TOMZ

TOMI Environmental Solutions Inc.

HOLD

Current Price

$0.75

Market Cap

15.2M

Sector

Finance

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$4.20

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOMZ
LPCN
Founded
1979
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
13.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOMZ
LPCN
Price
$0.75
$4.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.50
$7.00
AVG Volume (30 Days)
13.8K
35.7K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,688,341.00
$4,322,693.00
Revenue This Year
N/A
N/A
Revenue Next Year
$68.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$2.52
52 Week High
$1.50
$5.50

Technical Indicators

Market Signals
Indicator
TOMZ
LPCN
Relative Strength Index (RSI) 37.36 79.21
Support Level $0.73 $3.05
Resistance Level $0.80 $3.39
Average True Range (ATR) 0.02 0.23
MACD -0.00 0.07
Stochastic Oscillator 12.95 90.64

Price Performance

Historical Comparison
TOMZ
LPCN

About TOMZ TOMI Environmental Solutions Inc.

TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: